搜索临床试验以：锝[Tc-99m]硫胶体和铟[In-111]DTPA
总计40个结果
-
Navidea Biopharmaceuticals完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动，不招人
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); Mitaka USA, Inc.完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)完全的
-
Endomagnetics IncRegulatory and Clinical Research Institute Inc完全的
-
University of Washington招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
University of WashingtonNational Cancer Institute (NCI)完全的IIB 期肺癌非小细胞癌 AJCC v7 | IIIA 期肺癌非小细胞癌 AJCC v7 | IIIB 期肺癌非小细胞癌 AJCC v7美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)终止
-
Assiut University未知使用两种放射性药物评估分裂肾功能的差异：Tc-99m DTPA 和 Tc-99m DMSA 在肾脏患者中的应用
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动，不招人
-
University of ManitobaWinnipeg Regional Health Authority终止
-
University of California, San FranciscoBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma尚未招聘
-
Billy W. Loo Jr.终止
-
Sue O'DorisioNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的复发性前列腺癌 | 骨转移 | 第一阶段前列腺癌 | III期前列腺癌 | IV 期前列腺癌 | IIA 期前列腺癌 | IIB 期前列腺癌美国
-
British Columbia Cancer AgencyCanadian Institutes of Health Research (CIHR)完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动，不招人复发性子宫内膜腺癌 | 复发性子宫内膜癌 | 复发性子宫内膜透明细胞腺癌 | 复发性子宫内膜子宫内膜样腺癌 | 复发性子宫内膜混合细胞腺癌 | 复发性子宫内膜浆液性腺癌 | 复发性子宫内膜未分化癌 | IV 期子宫体癌 AJCC v7 | 复发性子宫体癌肉瘤 | 转移性子宫内膜癌美国
-
Eben RosenthalNational Cancer Institute (NCI)完全的